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The regulation of alternative splicing in the immune effector Dscam reported by Dong et al. (2012) in this issue
of Cell Host & Microbe raises important questions about the nature of immune responses. Can we clearly
define ‘‘adaptive’’ as being different from ‘‘innate’’ immunity, or is it time for a more flexible description?Many papers on invertebrate immunity
contain a statement that invertebrates
are ideal for studying innate immunity
because they lack adaptive immune
responses. In actuality, invertebrates
have spectacularly plastic immune effec-
tors that can generate true novelty and
functional immune response changes in
relation to past experience. The paper
by Dong et al. (2012) in this issue of Cell
Host & Microbe concerning the mecha-
nism behind alternative splicing of an
immune effector, Dscam, adds a mecha-
nistic dimension to the observed plas-
ticity of invertebrate immunity. However,
perhaps the most important contribution
of the Dong et al. (2012) study is the
demonstration of how difficult it is to
divide immune responses into strictly
‘‘innate’’ and ‘‘adaptive’’ properties.
Why might authors write that flies,
worms, snails, or sea urchins lack an
adaptive immune response? Typically,
the argument takes the following form: B
and T cells generate our adaptive immune
responses, therefore organisms with B
and T cells likely also have an adaptive
immune response. That is good logic.
Organisms lacking B and T cells are often
said to lack adaptive immunity, but it
is a logical fallacy to conclude that just
because an organism lacks these cells,
the organism will also lack an adaptive
immune response. These organisms
could simply generate a trained immune
response in another way. And they do.
To describe immunity, we plotted
known immune responses according to
their properties on two axes: molecular
specificity and memory. A historical
method of dividing innate from adaptive
immunity is to discuss the specificity of
the immune effectors. One could say
that innate immune effectors are germline394 Cell Host & Microbe 12, October 18, 201encodedwhile adaptive immune effectors
are not. This implies that an innate system
has a limited capacity to generate specific
effectors whereas the adaptive immune
system can create bespoke effectors
over the course of the host’s life span.
This approach doesn’t create two simple
categories; there is a continuum of
possibilities and no clear boundary that
can be used to draw a border between
adaptive and innate (Figure 1). We con-
sider five overlapping categories along
this continuum: first, there are single
immune effectors, like lysozyme or reac-
tive oxygen, which work nonspecifically
against a class of microbes. Second,
there are clouds of immune effectors
comprised of many effectors, like antimi-
crobial peptides or natural antibodies.
Third, there are effectors like antibodies
or VLRs that can be produced via recom-
bination or gene conversion. Fourth, anti-
bodies and snail FREPS can be altered
through somatic mutation to further
increase the range of specificity (Zhang
et al., 2004). Finally, there is RNAi, which
produces highly specific antiviral effec-
tors de novo. This is arguably the highest
form of specificity found in an immune
system because it produces tailor-made
effectors from the pathogen and has no
template in the host. This is as far from
innate as a host can get.
The memory axis can be divided into
four categories that are also drawn as
a continuum in the plot in Figure 1. First,
immune effectors can be expressed
constitutively. Second, effectors can be
stereotypically induced upon exposure
to microbes. Third, effectors can persist
following an immune response. This pro-
vides a sort of switch where the chal-
lenged animal is different from a naive
animal; for example, amplification of2 ª2012 Elsevier Inc.specific NK cells directed toward fighting
cytomegalovirus (CMV) fits this sort of
model (Sun et al., 2009). Finally, there
are responses that are trained by past
experience and increase upon a second
exposure. Antibody production following
a secondary infection is an obvious
example of this sort of training. Neuro-
immune reflexes could be placed pro-
vocatively at this end of the spectrum
as they open the possibility of neural
memory affecting the immune response
(Tracey, 2009). There is already evidence
for this in C. elegans (Zhang et al., 2005).
All of this is relevant to the Dscam gene
in insects because Dscam fits poorly into
our classical descriptions of immunity.
Considerable work has been published
on the role of Dscam molecules in wiring
the Drosophila nervous system, but
Dscam serves a second role as an
immune effector, and this has been less
well studied (Dong et al., 2006; Watson
et al., 2005). The Dscam gene in inverte-
brates is a complex gene that undergoes
alternative splicing. Theoretically, the
Dscam gene can generate up to 38,016
splice variants in dipterans (Dong et al.,
2006; Watson et al., 2005). Dscam can
be secreted where it can potentially act
as an opsonin, and in a membrane-bound
form it can potentially act as a phagocytic
receptor. Dscam is reported to be func-
tionally important in several invertebrate
systems including Drosophila and the
mosquito. In the absence of Dscam, these
hosts (or at least their cells) have trouble
raising an effective immune response
(Dong et al., 2006; Watson et al., 2005).
Ever since Dscam was implicated in
invertebrate immunity, there has been
some question about how much speci-
ficity the insect can squeeze out of these
molecules. Do these act like antibodies,
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Figure 1. A Map of Immune Effectors in Memory by Specificity Space
Immune responses are plotted qualitatively against two axes, memory and specificity. The memory
axis imagines induction profiles for two successive immune responses and categorizes the responses
with regard to how the host responds the second time it encounters a pathogen. The specificity axis
reports how many specific molecules can be produced as immune effectors and whether they are
germline encoded, partially encoded, or generated de novo upon an immune response. A discussion of
snail FREPS and sea urchin 185/333 molecules can be found in Buckley et al. (2008) and Zhang et al.
(2004). See text for more details.
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pressed in response to stimulation by an
antigen? Or is this just potential specificity
that is never realized because Dscam is
just expressed in the same cloud upon
every exposure? Dong et al. demonstrate
that the answer lies in between these two
extremes.
The authors of Dong et al. (2012) find
that different immune elicitors generate
different splicing patterns of Dscam,
tracing this through the pattern recogni-
tion pathways to the splicing factors
involved. Induction through the insect
immune deficiency (IMD) pathway regu-
lates splicing of Dscam through the
splicing factors Caper and/or IRSF1. The
authors demonstrated that Dscam alter-
native splicing is important for protec-
tion of the host from infection. If the host
is unable to splice appropriately for a
given microbe, then the host is more
susceptible. The authors present a model
whereby the nature of pattern recognition
signaling leads to the expression of
different clouds of alternatively spliced
Dscam molecules. Therefore, Dscam
defies simple descriptions. Dscam is a
non-germline-encoded immune effectorand resembles antibodies in this respect;
however, Dscam is not expressed as
a single highly specific molecule, but
rather it is produced as a cloud of effec-
tors with different specificities.
The paper by Dong and colleagues
places Dscam near the middle of Fig-
ure 1. The memory axis was not studied
in this paper; the authors report only
what happens during a primary immune
response. It would be interesting to
know how Dscam affects a second
immune response. Does the mosquito
do better upon a second challenge of
the same pathogen because there is ex-
isting Dscam protein from the previous
challenge? Is the correct cloud of Dscam
expressed more intensely upon re-
exposure? Does the mosquito do worse
upon a challenge with a second different
pathogen because the splicing is now
directed toward another pathogen?
The best-studied effectors in Figure 1
cover large swaths of the specificity by
memory space. For example, Drosophila
antimicrobial peptides (AMPs) are ex-
pressed as a cloud at the constitutive,
inducible, and switch levels. Antibodies,
considered as a class of molecules,Cell Host & Microbe 12work across the whole memory axis,
from constitutive expression to altered
second induction. We need to fill in the
missing spots for Dscam and all other
immune effectors.
There is a third axis that we left off
Figure 1: function. Some of the effectors
placed on the plot, like snail FREPS or
sea urchin 333/118 molecules, have inter-
esting molecular specificity properties,
but these have not been shown to func-
tionally affect memory. In contrast, there
many examples of functionally more
effective immune responses in inverte-
brates where we do not have enough
mechanistic information to place them
on the memory and specificity axes
(Pham et al., 2007; Rodrigues et al.,
2010). This figure will become more
complete as we resolve how each of
these systems work.
Studies such as the one from Dong
et al. (2012) should provoke immunolo-
gists to reassess their definition of ‘‘adap-
tation’’ and to look for signs of trained
immunity (Netea et al., 2011) in systems
that were originally considered innate
and stereotypical.REFERENCES
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